Kyle Gano
Corporate Officer/Principal chez NEUROCRINE BIOSCIENCES, INC.
Fortune : 19 M $ au 31/03/2024
Provenance du réseau au premier degré de Kyle Gano
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kyle Gano via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Public Communications Contact Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
| VOLCANO CORPORATION | Medical Specialties | Compliance Officer Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer General Counsel | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | President General Counsel | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
| University of Guelph | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree | |
| University of Arizona | College/University | Doctorate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| University of Nebraska Medical Center | College/University | Graduate Degree | |
| Washington State University | College/University | Undergraduate Degree | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Alameda County Community Food Bank
 Alameda County Community Food Bank Services to the Health IndustryHealth Services Alameda County Community Food Bank distributes nutritious food to low income county residents. The firm offers hunger and nutrition education programs. It promotes policies to benefit low-income residents. The company was founded in 1985 and is headquartered in Oakland, CA. | Services to the Health Industry | Director/Board Member | |
| International Society of Psychoneuroendocrinology | Corporate Officer/Principal | ||
CIO Executive Council
 CIO Executive Council Miscellaneous Commercial ServicesCommercial Services CIO Executive Council is a non-profit company that focuses on advancing business technology leaders. The company is based in Framingham, MA. The company provides strategic leadership development for the transforming c-suite at the world's most influential and evolving organizations. The company was founded in 2005 by Maryfran Johnson. Maryfran Johnson has been the CEO since 2005. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Treasurer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
| ORGANON & CO. | Pharmaceuticals: Major | Director/Board Member | |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Chairman |
Statistiques
Internationale
| Etats-Unis | 49 |
| Canada | 3 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 166 |
| Independent Dir/Board Member | 67 |
| Corporate Officer/Principal | 67 |
| Chairman | 33 |
| Undergraduate Degree | 30 |
Relations les plus connectées
| Insiders | |
|---|---|
| Leslie Norwalk | 46 |
| Stephen Sherwin | 26 |
| William Rastetter | 24 |
| Gary Lyons | 20 |
| Corinne Nevinny | 19 |
| Shalini Sharp | 17 |
| Christine Poon | 17 |
| Richard Pops | 17 |
| Alfred Sandrock | 16 |
| George Morrow | 16 |
| Joseph A. Mollica | 14 |
| David-Alexandre C. Gros | 13 |
| Ebun Garner | 11 |
| Tim Coughlin | 10 |
| Christopher Flint O'Brien | 10 |
